Orthostatic intolerance during early mobilization following video-assisted thoracic surgery. by Mizota, Toshiyuki et al.
Title Orthostatic intolerance during early mobilization followingvideo-assisted thoracic surgery.
Author(s)Mizota, Toshiyuki; Iwata, Yoshika; Daijo, Hiroki; Koyama,Tomohiro; Tanaka, Tomoharu; Fukuda, Kazuhiko
CitationJ urnal of anesthesia (2013), 27(6): 895-900
Issue Date2013-05-14
URL http://hdl.handle.net/2433/196866







Orthostatic intolerance during early mobilization following video-assisted thoracic surgery 
 
Toshiyuki Mizota, Yoshika Iwata, Hiroki Daijo, Tomohiro Koyama, Tomoharu Tanaka, 
Kazuhiko Fukuda 
Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan 
 
Corresponding author: Toshiyuki Mizota 
Mailing address: Department of Anesthesia, Kyoto University Hospital, 54 





Key words: orthostatic intolerance, video-assisted thoracic surgery, opioids, ambulation, 
analgesia 
 
Word count: 2,424 




Purpose: Early postoperative mobilization is crucial for early ambulation to reduce 
postoperative pulmonary complications after lung resection. However, orthostatic intolerance 
(OI) may delay patient recovery, leading to complications. It is therefore important to 
understand the prevalence of and predisposing factors for OI, which have not been established 
following video-assisted thoracic surgery (VATS).This study evaluated the incidence of OI, 
impact of OI on delayed ambulation, and predisposing factors associated with OI in patients 
after VATS. 
Methods: This retrospective cohort study consecutively analyzed data from 236 patients who 
underwent VATS. The primary outcome was defined as OI with symptoms associated with 
ambulatory challenge on postoperative day 1 (POD1), including dizziness, nausea and 
vomiting, feeling hot, blurred vision, or transient syncope. Multivariate logistic regression 
was performed to identify independent factors associated with OI. 
Results: Of the 236 patients, 35.2% (83) experienced OI; 45.8% of these could not ambulate at 
POD1, compared with 15.7% of patients without OI (P < 0.001). Factors independently 
associated with OI included advanced age [odds ratio 2.83 (1.46–5.58); P = 0.002], female 
gender [odds ratio 2.40 (1.31–4.46); P = 0.004], and postoperative opioid use [odds ratio 2.61 
(1.23–5.77); P = 0.012]. Use of thoracic epidural anesthesia was not independently associated 
with OI [odds ratio 0.72 (0.38–1.37); P = 0.318]. 
Conclusion: Postoperative OI was common in patients after VATS and significantly associated 
with delayed ambulation. Advanced age, female gender, and postoperative opioid use were 




Early ambulation following surgery is essential for early patient recovery. Otherwise, 
prolonged bed rest increases muscle loss and weakness, impairs pulmonary function, and 
predisposes patients to venous stasis and thromboembolism [1]. Protocols for enhanced 
recovery after surgery, such as optimized analgesia, early ambulation, and early return to 
normal diet, have been shown to improve postoperative outcomes in patients undergoing 
colorectal surgery [2–3]. However, postoperative orthostatic intolerance (OI) may delay 
ambulation and is characterized by symptoms such as dizziness, nausea and vomiting, feeling 
hot, blurred vision, and eventual syncope due to failed orthostatic cardiovascular regulation 
leading to a decrease in the arterial pressure, and cerebral hypoperfusion during standing [4]. 
Patients may be particularly vulnerable postoperatively to OI after ambulation because blood 
and fluid losses during surgery aggravate postural reduction in central blood volume while in 
the upright position. Transient inability to ambulate is observed after ambulatory surgery and 
is a major cause of prolonged hospital stay [5], and a high incidence of OI during early 
postoperative mobilization has been reported in patients after major surgery [6–8]. 
In thoracic surgery patients, postoperative pulmonary complications, including atelectasis, 
pulmonary infection, and respiratory failure, remain to be major clinical problems despite 
advances in surgical procedures and perioperative care [9]. A fast-track approach, such as 
early ambulation after lung resection, has been proposed in order to reduce postoperative 
pulmonary complications in patients undergoing lung resection [10]. Preventing OI and 
facilitating early ambulation are crucial components of the fast-track approach, but the 
incidence of OI during early ambulation and its impact on delayed ambulation after lung 
resection is unknown, and the predisposing factors associated with failed orthostasis are not 
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fully understood.  
In a previous study [8], we identified continuous postoperative intravenous infusion of 
fentanyl as an independent predisposing factor for OI following gynecologic laparoscopic 
surgery. However, we could not examine the effect of gender and epidural anesthesia on OI in 
the previous study. Although thoracic epidural anesthesia is commonly considered the “gold 
standard” for post-thoracotomy analgesia [11] and is widely used in thoracic surgery, epidural 
administration of local anesthetics may theoretically induce OI through 
sympathectomy-induced vasodilation. The effect of thoracic epidural anesthesia on the 
incidence of OI has not been clarified. 
The primary aim of this study was to determine the incidence of OI during early postoperative 
mobilization and its impact on delayed ambulation in patients undergoing video-associated 
thoracic surgery (VATS) for lung tumor resection. In addition, we examined the predisposing 
factors associated with OI. We were especially interested in evaluating the effect of epidural 




Materials and Methods 
This retrospective cohort study included patients who underwent VATS for lung tumor 
resection at Kyoto University Hospital from November 1, 2010 to October 31, 2011. Approval 
was obtained from the ethics committee of Kyoto University Hospital. Exclusion criteria were 
conversion to open thoracotomy (any incision extending beyond 15 cm) and postoperative 
admission to the intensive care unit. Data on patient characteristics (age at surgery, gender, 
height, body mass index, history of postoperative nausea and vomiting (PONV) or motion 
sickness, smoking status, and American Society of Anesthesiologists physical status), surgery 
(type of lung tumor, duration of surgery, and blood loss), anesthesia or analgesia (anesthetic 
agents and use of thoracic epidural anesthesia, intercostal nerve block, and postoperative 
opioids), and recovery profile (pain score and adverse events) were retrieved from the medical 
records of these patients. 
Selection of anesthetics and use of thoracic epidural anesthesia were left to the discretion of 
the attending anesthesiologist. Postoperative opioid use included continuous postoperative 
intravenous infusion of fentanyl and continuous postoperative epidural infusion of fentanyl 
combined with local anesthetics. For intravenous infusion of fentanyl, a Coopdech Syrinjector 
PCA Set (Daiken Medical Co., Ltd., Osaka, Japan) was used. Basal infusion rate was 1 ml/h, 
and bolus volume was 1 ml with a 10-min lockout time. For epidural infusion of fentanyl 
combined with local anesthetics (ropivacaine 0.2%), a Coopdech Balloonjector (Daiken 
Medical Co., Ltd.) was used. The infusion rate could be adjusted to 2, 4, and 6 ml/h. 
At the institution where the study was conducted, the patients were asked to stand up and 
walk in the morning and evening of postoperative day 1 (POD1). The patients were 
encouraged to walk around the ward (approximately 50 meters). A physical therapist recorded 
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each patient’s walking ability and also the symptoms experienced by the patient during the 
attempt to stand up and walk. 
The primary outcome of interest was defined as OI. The patients were considered to have OI 
if they experienced signs of cerebral hypoperfusion, defined as having symptoms such as 
dizziness, nausea and vomiting, feeling hot, blurred vision, or transient syncope during the 
ambulatory challenge on POD1. The symptoms as described in previous studies [6–8] were 
used as the basis for identification of OI; however, we could not use the objective criteria 
(decrease in systolic arterial pressure > 30 mmHg) as used by Jans et al. [7] because this was 
a retrospective study. Ambulation was considered to be delayed if the patient could not walk 
around the ward without assistance on POD1. For patients with delayed ambulation, data on 
reasons for delayed ambulation were also collected. 
Statistical analysis 
Data were analyzed using JMP version 8.0 (SAS Institute Japan Ltd., Tokyo, Japan). The data 
are presented as median (interquartile range) and number (percentage), unless stated 
otherwise. Differences between groups were compared using the Mann–Whitney U test for 
continuous variables. For categorical variables, the Pearson chi-square test or Fisher exact test 
was used where appropriate. All the statistical tests were two tailed. Except for entering 
multivariate models, statistical significance was set at P < 0.05. 
The covariates considered in the multivariate models included age (less than 75 years, 75 or 
more years), gender, body mass index (less than 30 kg/m2, at least 30 kg/m2), history of 
PONV or motion sickness, smoking status, and American Society of Anesthesiologists 
physical status (1,2, or 3), duration of surgery (less than 4 h, 4 h or more), blood loss (less 
than 200 ml, at least 200 ml), anesthetics used, use of thoracic epidural anesthesia, and 
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postoperative opioid use. All covariates were entered into multivariate analysis for which a 
backward stepwise multivariable logistic regression was performed to seek independent 
factors associated with OI. All variables maintaining a P value of ≤0.1 were included in the 
final model. Use of epidural anesthesia was forced into logistic models regardless of the 





A total of 240 patients underwent VATS during the study period. After excluding three 
patients whose operation was converted to open thoracotomy and one patient who was 
admitted to intensive care unit after operation, data from 236 eligible patients were analyzed. 
Patients had a median (range) age of 68 (30–85) years, weight (range) 58 (37–104) kg, and 
height (range) 167 (138–183) cm, and 99 (41.9%) patients were female. 
Eighty-three (35.2 %) patients experienced OI and 62 (26.3 %) patients could not ambulate on 
POD1; 45.8% of patients with OI could not ambulate at POD1, compared to 15.7% of patients 
without OI (P < 0.001). Among 62 patients who could not ambulate on POD1, 38 (61.3 %) 
patients experienced OI during ambulation challenge. The reasons for delayed ambulation are 
described in Table 1. Thirty-three (53.2%) patients failed to ambulate because of OI 
symptoms (nausea, vomiting, dizziness, or syncope), and seven (11.3%) patients failed to 
ambulate because of wound pain. 
The clinical characteristics of the study population and the univariate association with OI are 
described in Table 2. After stepwise backward logistic regression analysis, the variables that 
remained in the final model as independent predictors of OI were advanced age [odds ratio 
2.83 (1.46–5.58); P = 0.002], female gender [odds ratio 2.40 (1.31–4.46); P = 0.004], and 
postoperative opioid use [odds ratio 2.61 (1.23–5.77); P = 0.012] (Table 3). Use of thoracic 
epidural anesthesia was not independently associated with OI [odds ratio 0.72 (0.38–1.37); P 
= 0.318]. 
Because intravenous opioid and epidural opioid may have different effects on OI and delayed 
ambulation, we compared the incidence of OI and delayed ambulation among three groups 
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(no postoperative opioid, postoperative intravenous opioid, and postoperative epidural opioid) 
(Table 4). One hundred and twelve patients received continuous postoperative intravenous 
infusion of fentanyl with the median rate of infusion of 25 µg/h (range: 8.3–48.1 µg/h). The 
Coopdech Syrinjector PCA Set, the device used for continuous postoperative intravenous 
infusion of fentanyl, was designed for patient-controlled analgesia, and the bolus dose was 
requested at median (range) 0 (0–6) times 24 h postoperatively. Fifty-three patients received 
continuous postoperative epidural infusion of fentanyl with the median rate of infusion of 
13.3 µg/h (range: 1.4–30.2 µg/h). The incidence of OI was higher in patients who received 
intravenous (44.6%) or epidural (35.9%) infusion of fentanyl than in patients who received no 





The primary aim of this study was to determine the incidence of OI during ambulation 
challenge after VATS. We found that as high as 35.2% of patients experienced OI during the 
ambulation challenge on POD1. The incidence of OI on POD1 in this study was higher than 
that reported in previous reports (12%–19 %) [6–8]. In addition to the difference in patient 
characteristics or surgical procedure, continuous postoperative administration of fentanyl may 
account for the relatively high incidence of OI. We also found that OI was significantly 
associated with delayed ambulation and that symptoms of OI were the main causes of delayed 
ambulation after VATS. In contrast, wound pain was not a leading cause of delayed 
ambulation. Because OI was the major cause of delayed ambulation after VATS, it is essential 
to ameliorate OI to facilitate recovery. 
Although the definition of OI includes PONV during ambulation challenge and PONV is 
widely used to assess the symptoms among postoperative patients, we used OI instead of 
PONV to assess symptoms during ambulation challenge in this study. There are two reasons 
for this. First, the authors considered that the symptoms which are not recognized as PONV 
(dizziness and blurred vision) are also important because they also make patients discomfort 
and may delay ambulation. In fact, among 83 patients who experienced OI on POD1, 31 
(37.3%) patients were judged not to have PONV. Second, PONV includes nausea and 
vomiting that is not associated with ambulation (for example, PONV immediately after 
extubation). The authors considered that identifying ambulation-associated symptoms is 
important to facilitate ambulation. 
We identified postoperative opioid use as an independent predisposing factor for OI after 
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VATS. This result is consistent with our previous study, which reported that postoperative 
opioid infusion (median infusion rate: 40 µg/h) is associated with OI in patients after 
gynecologic laparoscopic surgery [8]. Although the infusion rate of fentanyl in the present 
study (median infusion rate: 25 µg/h for intravenous infusion, 13.3 µg/h for epidural infusion) 
was lower than that in the previous study, there was a significant association between 
postoperative infusion of fentanyl and OI. In contrast to the previous study in which only 
postoperative opioid infusion was identified as a predisposing factor for OI, advanced age and 
female gender were also identified as independent predisposing factors for OI in the present 
study. We suspect that the previous study could not identify advanced age as a predisposing 
factor for OI because it did not include aged people (the oldest patient was 66 years old, and 
96% of the patients were less than 50 years old).  
Two of the three predisposing factors for OI identified in this study, viz., female gender and 
postoperative opioid use, are also known as predisposing factors for PONV [12]. In addition, 
although it was not statistically significant, history of PONV or motion sickness, which is also 
one of the well-known predisposing factors for PONV, seemed to be associated with OI (P 
value = 0.075). We suspect that OI is caused, at least in part, by common mechanism as that 
of PONV. 
Although epidural administration of local anesthetics may theoretically induce OI through 
sympathectomy-induced vasodilation, the use of thoracic epidural anesthesia itself was not 
associated with OI during the ambulation challenge in this study. This result suggests that 
continuous postoperative epidural administration of ropivacaine 0.2% at 2–6 ml/h does not 
induce clinically significant vasodilation. 
The results of this study suggest that epidural as well as intravenous infusion of fentanyl 
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causes OI. The mechanism of analgesia after epidural administration of fentanyl is considered 
to be primarily systemic, and epidural administration of fentanyl can cause systemic adverse 
effects such as sedation, respiratory depression, pruritus, nausea, and vomiting [13]. It is 
reasonable to consider that epidural infusion of fentanyl has the same effect on OI as 
intravenous infusion. Although thoracic epidural analgesia with local anesthetics and opioids 
is recommended for post-thoracotomy analgesia [11], epidural opioids may provide less 
benefit to the patients undergoing VATS because VATS is associated with less postoperative 
pain [14]. The balance of benefit and harm needs to be considered when using epidural 
opioids after VATS.  
We found that postoperative opioid infusion is significantly associated with OI and may delay 
ambulation after VATS. In contrast, it was difficult to determine the analgesic efficacy of 
postoperative opioid infusion in this study. To the best our knowledge, there are no previous 
studies that compared the analgesic efficacy of postoperative opioid infusion with that of 
other reported pain treatments for VATS, i.e., nonsteroidal anti-inflammatory drugs, 
paravertebral block with local anesthetics, and surgical wound infiltration [15–17]. If one of 
these pain treatments or their combinations have equivalent analgesic efficacy to 
postoperative opioid infusion, using them instead of postoperative opioid infusion may reduce 
OI and facilitate early ambulation. Future studies are required to seek an optimal analgesic 
strategy after VATS. 
The major limitation of this study is its retrospective design. This study represents data from 
one institution. We could not use the objective criteria (decrease in systolic arterial pressure 
>30 mmHg) as used by Jans et al. [7] for the identification of OI. Despite these limitations, 
these data provide new information regarding the incidence and predisposing factors for OI 
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and delayed ambulation in patients after VATS. 
In conclusion, the present study found a high incidence (35.2 %) of OI during ambulation 
challenge on POD1 after VATS and significant association between OI and delayed 
ambulation. Three independent predisposing factors for OI (advanced age, female gender, and 
postoperative opioid use) were identified. Multimodal opioid-sparing postoperative pain 
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Nausea or vomiting 28 45.2 
Wound pain 7 11.3 
Dizziness 4 6.5 
Fatigue 4 6.5 
Dyspnea 2 3.2 
Syncope 1 1.6 
Other 16 25.8 






Table 2 Univariate Analysis of Potential Predictors of Orthostatic Intolerance 
 
Variable No OI (n = 153) OI (n = 83) P value 
Age 68 (61–73) 71 (64–77) 0.020 
Female gender 54 (35.3%) 45 (54.2%) 0.005 
Height (cm) 163.2 (157–168.2) 160 (152–165.3) 0.007 
BMI (kg/m2) 22.1 (20.3–24.7) 22.5 (20.4–24.1) 0.758 
ASA-PS (1/2/3) 41/97/15 18/61/4 0.219 
Current smoker 22 (14.4%) 11 (13.3%) 0.812 
History of PONV or MS 20 (13.1%) 24 (28.9%) 0.003 
Metastatic / primary 43/110 11/72 0.010 
Duration of surgery (min) 174 (111–234) 183 (143.5–223.5) 0.385 
Bleeding (ml) 25 (0–76.5) 30 (0–82) 0.605 
TIVA 41 (26.8%) 31 (37.3%) 0.093 
Epidural anesthesia 81 (52.9%) 32 (38.6%) 0.035 
Postoperative opioid use 96 (62.7%) 69 (83.1%) 0.001 
 
Continuous variables were presented as a median (inter-quartile range), and categorical 
variables were presented as a number (percentage). 
OI, orthostatic intolerance; BMI, body mass index; ASA-PS, American Society of 
Anesthesiologists classification of physical status; PONV, postoperative nausea and vomiting; 




Table 3 Multivariate Analysis of Independent Predisposing Factors of Orthostatic Intolerance 
Variables Coefficient SE Adjusted odds ratio P value 
Intercept −1.96 0.46 - <0.001 
Advanced age 1.04 0.34 2.83 (1.46–5.58) 0.002 
Female gender 0.87 0.31 2.40 (1.31–4.46) 0.004 
History of PONV or MS 0.65 0.37 1.93 (0.93–4.00) 0.075 
Postoperative opioid use 0.96 0.39 2.61 (1.23–5.77) 0.012 
Use of epidural anesthesia −0.33 0.33 0.72 (0.38–1.37) 0.318 
Intercept is a mathematical constant (no clinical interpretation). SE, standard error; PONV, 
postoperative nausea and vomiting; MS, motion sickness 




Table 4 Recovery Profile by Route of Postoperative Fentanyl Infusion 
 
Continuous variables were presented as a median (inter-quartile range), and categorical 
variables were presented as a number (percentage). 
OI, orthostatic intolerance 
Pain at rest and pain on movement was assessed using 11-point-numeric rating scale on 




opioids (n = 71) 
Postoperative epidural 
opioids (n = 53) 
Postoperative intravenous 
opioids (n = 112) 
Rate of fentanyl 
infusion (µg/h) 
- 13.3 (10–16.7) 25 (20–30) 
Use of epidural 
anesthesia 
58 (81.7) 53 (100) 2 (1.8) 
Use of intercostal 
nerve block 
5 (7.0) 0 (0) 47 (42.0) 
OI 14 (19.7) 19 (35.9) 50 (44.6) 
Delayed 
ambulation 
13 (18.3) 18 (34.0) 31 (27.7) 
Pain at rest 1 (0–3) 0 (0–3) 2 (0.25–3) 
Pain on 
movement 
3 (1–6) 2 (0–5) 5 (3–6) 
